Poultry Pharmaceuticals Market

Introduction: -

Poultry medicines, called avian medicines or veterinary medicines for poultry, include a number of pharmaceutical drugs specially formulated to promote the health and general well-being of poultry, including chickens, turkeys, ducks and other birds. The avian pharmaceutical sector has a significant impact on healthcare systems worldwide, from patients in need of medication to clinicians interested in cutting-edge research. Staying up to date with the latest market developments is essential for success. Poultry drug manufacturers strengthen the birds' immune systems so that they produce antibodies much faster to fight against invaders, stopping the spread of a certain disease. Chickenpox vaccines are critical to preventing disease. In the development of vaccines, the focus is mainly on the fight against viral infections in birds. Vaccines can be administered through the nose, mouth, eyes, skin or muscles.

The number of approved drugs and the need for poultry vaccination to treat diseases are expected to drive the market expansion during the forecast period. The profitability and productivity of a poultry farm is directly related to the quality of bird health. However, the use of poultry vaccines has many consequences mild discharge from the eyes and nose, local swelling and discomfort at the injection site, loss of appetite and energy, sneezing, mild fever and mild cough are all symptoms that can. takes place at the location. Thus, this aspect presents a challenge for market expansion. The spread of COVID-19 has significantly affected the demand for bird health care. Animal products such as meat, milk and eggs initially struggled to meet demand due to the disruption of the supply chain caused by the international export ban. As the number of reported cases of COVID-19 decreased, trade and agricultural production increased, resulting in better care and nutrition for chickens, increased demand for poultry healthcare, and the market advanced during the forecast period. Increasing prevalence of zoonoses and increasing demand for poultry-based foods are all factors that are boosting the growth of the market.

The global Poultry Pharmaceuticals Market value was 7.19 billion in 2024, it is Expected to Hit 14.90 billion by 2032 with CAGR of 8.68%

Market overview: -

The poultry pharmaceutical market includes various veterinary medicines and nutritional supplements adapted to the health and well-being of poultry. This includes antibiotics, vaccines, parasiticides and nutritional supplements designed to prevent and treat disease, improve growth rates and improve overall poultry productivity. Factors such as increasing demand for poultry products, growing concern about diseases and advancements in veterinary medicine are driving the market growth. Regulation of antibiotic use and growing consumer preference for organic poultry products are also shaping market dynamics, promoting alternative treatments and sustainable practices in the industry.

Poultry Pharmaceuticals Market

Size, by Product, - (USD Billion)

Antibiotics

Vaccines

Parasiticides

Feed Additives

Other Products

The Market will Grow

At the CAGR of:

8.68%

The Forecast Market

Size for in USD:

$ 14.90 billion

Key market Growth factor: -

One of the major growth factors for the poultry products market is the increasing demand for poultry products across the world. As the world's population grows and dietary patterns shift to a protein-rich diet, the demand for poultry and eggs continues to grow. This increased demand requires the introduction of effective preventive and curative measures, which increase the demand for medicines adapted to chicken health. In addition, advances in veterinary medicine and biotechnology allow the development of innovative products that improve the health and productivity of poultry. In addition, growing food safety concerns and regulatory pressure to reduce the use of antibiotics in poultry farming will further stimulate market growth, encouraging the adoption of alternative treatment solutions.

Some Major Key Players In The Poultry Pharmaceuticals Market: -

• Aervoe Industries Inc.
• Bayer AG,
• Bimeda
• Ceva Sante Animale
• Elanco Animal Health (Eli Lilly and Company)
• Merck Animal Health
• Merial Animal Health (Sanofi)
• Virbac
• Boehringer Ingelheim
• Zoetis, Inc.
• Pacific GeneTech
• Avivagen Inc.
• Hester Biosciences Limited
• Venkys India
• Calier

• KM Biologics

  Poultry Pharmaceuticals Market

  Share, by end user, (USD Billion)

  7.19 billion%

  Broilers

  Layers

  Turkeys

  Breeders

  Other End-Users

  

  14.90 billion

  Total Market Size

  USD (Billion),

  8.68%

  CAGR

  -

Market segmentation: -

By Types of Products

• Antibiotics
• Vaccines
• Parasiticides
• Feed Additives
• Nutritional Supplements
• Others

Applications

• Broilers
• Layers
• Turkeys
• Breeders
• Others

Regions:

North America

• United States
• Canada
• Mexico

Europe

• United Kingdom
• Germany
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia-Pacific

Latin America

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

• Rest of Middle East & Africa

  Poultry Pharmaceuticals Market

  Size, by Product, - (USD Billion)

  The Market will Grow

  At the CAGR of:

  8.68%

  The Forecast Market

  Size for in USD:

  $ 14.90 billion

  

Trends: -

A few key trends are shaping the avian pharmaceuticals market. First, there has been a significant shift towards organic and natural solutions, driven by consumer demand for safer and more sustainable poultry products. Second, advances in biotechnology facilitate the development of new vaccines and feed additives, improving disease resistance and growth rates in poultry. Third, precision farming techniques are increasingly emphasized by technologies such as the Internet of Things and artificial intelligence to optimize health management and production efficiency. Finally, strict regulations on the use of antibiotics force the industry to investigate alternative treatment and preventive measures, promoting the use of probiotics and herbal supplements in poultry health.

Opportunities: -

The poultry pharmaceutical market offers several promising opportunities for growth and innovation. First, the increasing global demand for poultry products due to population growth and increasing protein consumption creates a significant market opportunity for pharmaceutical companies to develop and introduce new products that serve the health and productivity of poultry. Second, technological advances such as precision farming, the Internet of Things and artificial intelligence offer opportunities to improve disease control, optimize feed formulations and improve production efficiency in poultry farming. Third, increasing consumer awareness of food safety and animal welfare opens up opportunities for the development and marketing of high-quality and high-quality poultry medicines. In addition, expansion into emerging markets, particularly Asia Pacific and Latin America, offers untapped opportunities for market penetration and growth. Finally, collaborations between pharmaceutical companies and research institutions can facilitate the development of innovative solutions, such as new vaccines and natural alternatives, to address emerging challenges in bird health. 

Restraints: - 

Several constraints challenge the poultry medicine market. Stricter regulations on the use of antibiotics in poultry production limit the availability and use of traditional medicines. In addition, concerns about microbial resistance are forcing the industry to look for alternative treatments, increasing research and development costs. Economic factors such as fluctuating raw material prices and strict quality control standards further erode profit margins. In addition, cultural and consumer preferences for antibiotic-free and organic poultry products are increasing the demand for natural alternatives, increasing competition in the market. Finally, limited awareness and adoption of advanced health practices in developing regions pose challenges to market expansion in these regions.

Poultry Pharmaceuticals Market TO (USD BN)

CAGR OF

8.68%

Poultry Pharmaceuticals Market

14.90 billion%

Recent development: -

1. Ottawa, ON /Business Wire/ June 6, 2023/ Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, has announced its unaudited financial results for the Second quarter of 2023.
2. RAHWAY, N.J., June 4, 2024 – Merck Animal Health, known as MSD Animal Health outside  of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the presentation of more than 30 studies at the 27th International Pig Veterinary Society Congress (IVPS) and 15th European Symposium of […]